LSU researchers and drug company Skymount Medical are beginning studies on COVID-19 patients involving a combination of medicines, known as SM-19, that have shown to reduce viral load in initial tests, according to an announcement from Skymount. The combination was discovered using the artificial intelligence platform DeepDrug, which was created at LSU and is designed
LSU AI platform used to create COVID-19 treatment
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
